Mirion Technologies (MIR) closed at $16.22 with a mean analyst price target of $24, suggesting 48% upside potential. The stock has a Zacks Rank #2 (Buy) rating and shows positive earnings estimate revisions over the last 30 days. However, the article cautions that price targets alone should not be the sole basis for investment decisions, as analysts often set overly optimistic targets due to business incentives.

Mirion Technologies has been upgraded to a Zacks Rank #2 (Buy) rating, reflecting rising earnings estimates over the past three months. The upgrade positions the company in the top 20% of Zacks-covered stocks, suggesting potential near-term stock price appreciation driven by improving business fundamentals and institutional investor interest.

Christopher A. Moore, Chief Accounting Officer of Mirion Technologies, sold 8,400 shares worth $165,000 on May 7, 2026, representing 27.49% of his direct holdings. The sale is characterized as likely routine portfolio management. While the company benefits from growing nuclear energy and radiation safety markets, analysts suggest current share prices already reflect this optimism, and the company faces uneven earnings performance and stock volatility.

Nicholas Investment Partners sold 592,382 shares of Mirion Technologies (MIR) worth approximately $13.36 million in Q1 2026, despite the company posting strong 27.5% revenue growth and 42% order surge. The fund's stake reduction suggests investor rotation despite solid operational performance, though profitability concerns and underperformance versus the S&P 500 may be driving the decision.

The global medical radiation detection devices market is projected to grow at ~7% CAGR through 2032, driven by rising cancer incidence, increased diagnostic imaging adoption, and stricter radiation safety regulations. North America leads the market, with Geiger-Müller counters as the largest product segment. Key players include Thermo Fisher Scientific, Ludlum Measurements, Mirion Technologies, and Canon Inc.

Mirion Technologies saw an 18% stock rally after reporting strong Q3 earnings, driven by growth in nuclear radiation detection equipment, particularly for AI data center infrastructure support.

Mirion Technologies reported strong Q2 2025 earnings, with revenue of $222.9 million and adjusted EPS of $0.11, beating analyst expectations. The company raised full-year revenue guidance and continues to focus on nuclear energy and medical radiation markets.

Evome Medical Technologies Inc. announced an amendment to its forbearance agreement with Biodex Rehab Systems, LLC and Biodex Medical Systems, Inc., reducing its debt from $6.7 million to $4.25 million due in 2030, in exchange for Biodex Medical extending its contract manufacturing agreement with Mirion Technologies (Capintec), Inc.

The Omega Advisors CEO said he has lost interest in the S&P 500 stock index as he claimed only "mispriced" stocks now interest him

The most overbought stocks in the information technology sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70. Here’s the latest list of major overbought players in this sector. Iris Energy Limited (NASDAQ: IREN) Iris Energy said it is increasing its self-mining capacity from 2.0 EH/s to 5.5 EH/s. The company’s stock has a 52-week high of $17.97 . RSI Value: 72.70 IREN Price Action: Shares of Iris Energy gained 20.2% to close at $2.56 on Tuesday and added 2% in after-hours trading. SkyWater Technology, Inc. (NASDAQ: SKYT) SkyWater Technology ...

Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results. Benefitfocus, Inc. (NASDAQ: BNFT) shares surged 48.2% to settle at $10.36 on Wednesday after the company announced it will be acquired by Voya Financial for $10.50 per share. Forza X1, Inc. (NASDAQ: FRZA) climbed 45% to close at $2.45 after the company announced it received 50 electric boat reservations in the last 90 days, potentially resulting in over $8.5 million in revenue. Bandwidth Inc. (NASDAQ: BAND) rose 41.6% to close at $17.42 after the company reported better-than-expected Q3 sales results. The company also issued Q4 and FY22 sales guidance above analyst estimates. Rayonier Advanced Materials Inc. (NYSE: RYAM) shares gained 34.2% to close at $6.00 as the company posted upbeat quarterly results. Chegg, Inc. (NYSE: CHGG) gained 22% to close at $25.75 after the company reported better-than-expected Q3 results. The company also issued FY22 sales guidance above analyst estimates. Huadi International Group Co., Ltd. (NASDAQ: HUDI) climbed 21.3% to close at $30.84. Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares gained 18.7% to close at $21.69 after the company announced collaboration with CSL to develop and commercialize self-amplifying mRNA vaccines. Arcturus to receive upfront payment of $200 million. Codiak BioSciences, Inc. (NASDAQ: CDAK) climbed 18% to close at $0.9082. Quad/Graphics, Inc. (NYSE: QUAD) climbed 17.8% to close at $3.17 after the company reported Q3 EPS and sales results up from last year. The company also raised its FY22 sales growth expectations. Cocrystal Pharma, Inc. (NASDAQ: COCP) climbed 15.8% to close at $2.79. Cocrystal Pharma was granted European patent covering oral antiviral candidate CC-42344 in combination with another antiviral agent for the treatment of influenza. Rail Vision Ltd. (NASDAQ: RVSN) surged 14.7% to settle at $0.7982. LSI Industries Inc. (NASDAQ: LYTS) jumped 14.2% to close at $8.91 following strong quarterly earnings. Mercury General Corporation (NYSE: MCY) gained 14.1% to close at $33.06 following strong quarterly earnings. CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) jumped 13.6% to close at $0.1998. CNS Pharmaceuticals announced dosing of first patient in europe/france in ongoing potentially pivotal global trial evaluating Berubicin for the treatment of GBM, an aggressive and incurable form of brain cancer. Frequency Therapeutics, Inc. (NASDAQ: FREQ) gained 13.4% to settle at $2.03 after Baird initiated coverage on the stock with an Outperform rating and $10 price target. BZ Wire 9F Inc. (NASDAQ: JFU) gained 13.2% to close at $0.2550. Sun Country Airlines Holdings, Inc. (NASDAQ: SNCY) gained 12.7% to close at $18.45 following Q3 results. UFP Technologies, Inc. (NASDAQ: UFPT) rose 12.7% to settle at $104.63 following Q3 results. Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 12.5% to settle at $0.63. Super Micro Computer, Inc. (NASDAQ: SMCI) rose 12.5% to close at $80.84 after the company reported better-than-expected Q3 EPS and sales results. Lindblad Expeditions Holdings, Inc. (NASDAQ: LIND) jumped 12.2% to close at $9.32 following strong Q3 results. Li Auto Inc (NASDAQ: LI) gained 12.1% to settle at $16.32. Li Auto recently reported it delivered 10,052 vehicles in October 2022, up 31.4% year over year. OneSpan Inc. (NASDAQ: OSPN) surged 11.8% to settle at $11.63 following Q3 results. RLX Technology Inc. (NYSE: RLX) gained 11.7% to settle at $1.53 after climbing around 10% on Tuesday. United Therapeutics Corporation (NASDAQ: UTHR) climbed 11.1% to ...

Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results. Benefitfocus, Inc. (NASDAQ: BNFT) shares jumped 47.8% to $10.33 after the company announced it will be acquired by Voya Financial for $10.50 per share. Akso Health Group (NASDAQ: AHG) gained 44% to $0.7280. Rayonier Advanced Materials Inc. (NYSE: RYAM) shares climbed 40.9% to $6.30 as the company posted upbeat quarterly results. Forza X1, Inc. (NASDAQ: FRZA) jumped 39% to $2.3495 after the company announced it received 50 electric boat reservations in the last 90 days, potentially resulting in over $8.5 million in revenue. Bandwidth Inc. (NASDAQ: BAND) gained 36.9% to $16.84 after the company reported better-than-expected Q3 sales results. The company also issued Q4 and FY22 sales guidance above analyst estimates. Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares rose 32.8% to $24.30 after the company announced collaboration with CSL to develop and commercialize self-amplifying mRNA vaccines. Arcturus to receive upfront payment of $200 million. Lindblad Expeditions Holdings, Inc. (NASDAQ: LIND) jumped 31.1% to $10.91 following strong Q3 results. Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) gained 29.3% to $3.22. Huadi International Group Co., Ltd. (NASDAQ: HUDI) surged 29.3% to $32.88. Chegg, Inc. (NYSE: CHGG) rose 24.2% to $26.23 after the company reported better-than-expected Q3 results. The company also issued FY22 sales guidance above analyst estimates. electroCore, Inc. (NASDAQ: ECOR) jumped 21% to $0.3568. Sun Country Airlines Holdings, Inc. (NASDAQ: SNCY) gained 19.5% to $19.56 following Q3 results. Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 17.3% to $2.83. Cocrystal Pharma was granted European patent covering oral antiviral candidate CC-42344 in combination with another antiviral agent for the treatment of influenza. Quad/Graphics, Inc. (NYSE: QUAD) gained 17.1% to $3.15 after the company reported Q3 EPS and sales results up from last year. The company also raised its FY22 sales growth expectations. trivago N.V. (NASDAQ: TRVG) jumped 16.8% to $1.2150. 9F Inc. (NASDAQ: JFU) gained 16.3% to $0.2620. Codiak BioSciences, Inc. (NASDAQ: CDAK) jumped 16.2% to $0.8950. Super Micro Computer, Inc. (NASDAQ: SMCI) rose 16% to $83.38 after the company reported better-than-expected Q3 EPS and sales results. VEON Ltd. (NASDAQ: VEON) jumped 15.7% to $0.4050. VEON said it is conducting a sale process for its Russian ...